The present invention relates to a new industrial feasible process for the preparation of Gabapentin Form-II by converting the Gabapentin hydrochloride salt directly into Form-II without the formation of Form-III by neutralizing the Gabapentin hydrochloride solution with a base at higher temperatures followed by cooling to yield Gabapentin Form-II with chloride ions less than 100 ppm with respect to Gabapentin.
